Vitamin B12 Deficiency
Deficiency causing megaloblastic macrocytic anaemia and neurological damage (subacute combined degeneration of the cord). Pernicious anaemia (autoimmune) is the commonest cause in the UK. Neurological damage may be irreversible if treatment delayed.
Key Facts
Macrocytic megaloblastic anaemia: MCV >100 fL, oval macrocytes, hypersegmented neutrophils on blood film Pernicious anaemia: commonest cause in UK; autoimmune destruction of gastric parietal cells → loss of intrinsic factor → B12 malabsorption Anti-intrinsic factor antibodies: ~50% sensitive but highly specific for pernicious anaemia; anti-parietal cell antibodies ~90% sensitive but less specific Subacute combined degeneration of the cord (SACD): demyelination of dorsal columns (loss of vibration/proprioception) and lateral corticospinal tracts (UMN signs) — may occur WITHOUT anaemia Treatment: hydroxocobalamin 1mg IM on alternate days × 2 weeks (loading), then every 2–3 months for life (if pernicious anaemia) CRITICAL: treat B12 deficiency BEFORE folate — giving folate alone may precipitate/worsen neurological damage Other causes: dietary (vegans/vegetarians), gastrectomy, ileal resection (terminal ileum absorbs B12), metformin, nitrous oxide abuse Neurological features may be irreversible if treatment delayed — treat urgently if neurological symptoms present
Overview
Key Facts
Vitamin B12 (cobalamin) deficiency causes megaloblastic anaemia and potentially irreversible neurological damage. Pernicious anaemia is the commonest cause in the UK.
Epidemiology
- Prevalence: ~6% of >60 years; higher in vegans (~50%)
- Pernicious anaemia: F:M 1.6:1; peak age 60–70; associated with other autoimmune conditions (thyroid, vitiligo, Addison)
Aetiology
- Pernicious anaemia (most common in UK): autoimmune atrophic gastritis → destruction of parietal cells → loss of intrinsic factor → B12 malabsorption
- Dietary: vegans, vegetarians (B12 found only in animal products)
- Malabsorption: gastrectomy, ileal resection (terminal ileum), Crohn disease (terminal ileum), bacterial overgrowth, fish tapeworm (Diphyllobothrium latum)
- Drugs: metformin, PPIs, H2 receptor antagonists, nitrous oxide (inactivates B12)
Pathophysiology
- B12 is cofactor for methionine synthase (homocysteine → methionine) and methylmalonyl-CoA mutase
- Deficiency → impaired DNA synthesis (megaloblastic change) and impaired fatty acid metabolism (neurological damage)
- Megaloblastic: defective DNA synthesis → nuclear-cytoplasmic dissociation → large immature RBCs (megaloblasts)
- Neurological: accumulation of methylmalonic acid → demyelination of dorsal columns and lateral corticospinal tracts
Clinical Presentation
Haematological
- Gradual onset anaemia symptoms: fatigue, dyspnoea, pallor
- Mild jaundice (lemon-yellow tinge — from ineffective erythropoiesis/haemolysis)
- Glossitis (smooth, beefy-red tongue)
- Angular stomatitis
Neurological (may occur WITHOUT anaemia)
- Subacute combined degeneration of the cord:
- Dorsal columns: loss of vibration sense, proprioception, positive Romberg, sensory ataxia
- Lateral corticospinal tracts: upper motor neuron signs (hyperreflexia, extensor plantars, spasticity)
- Peripheral neuropathy: glove-and-stocking paraesthesiae
- Cognitive: memory impairment, confusion, dementia
- Psychiatric: depression, psychosis ('megaloblastic madness')
- Optic atrophy: rare
Red Flags
- Neurological symptoms (SACD) — treat URGENTLY; may be irreversible
- Cognitive decline in elderly (consider B12 deficiency as reversible cause)
- Young patient with macrocytic anaemia (dietary, autoimmune)
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| Folate deficiency | Macrocytic, megaloblastic, NO neurological damage | Serum/red cell folate |
| Hypothyroidism | Macrocytic (non-megaloblastic), fatigue, weight gain | TFTs |
| Myelodysplasia | Elderly, macrocytic, cytopenias, dysplastic blood film | Bone marrow biopsy |
| Liver disease/alcohol | Macrocytic (non-megaloblastic), raised GGT, liver disease features | LFTs, GGT |
| Reticulocytosis | High MCV due to large reticulocytes (haemolysis, bleeding) | Reticulocyte count |
Diagnosis / Investigation
Bloods
- FBC: low Hb, raised MCV (>100 fL), ± low WCC and platelets (pancytopenia in severe cases)
- Blood film: oval macrocytes, hypersegmented neutrophils (≥5 lobes), anisopoikilocytosis
- Serum B12: low (<150 ng/L)
- Methylmalonic acid (MMA): elevated (more sensitive; confirms tissue deficiency)
- Homocysteine: elevated (non-specific; also raised in folate deficiency)
- Anti-intrinsic factor antibodies: ~50% sensitive, highly specific for pernicious anaemia
- Anti-gastric parietal cell antibodies: ~90% sensitive but less specific
- Reticulocyte count: low (inappropriately)
- LDH, bilirubin: elevated (ineffective erythropoiesis/intramedullary haemolysis)
- Serum folate: check simultaneously (treat B12 first if both deficient)
Imaging/Special Tests
- MRI spine: SACD — high signal in dorsal columns and lateral corticospinal tracts on T2
- Gastroscopy: if pernicious anaemia confirmed (risk of gastric carcinoid and gastric adenocarcinoma — but routine surveillance debated)
- Schilling test: historical; no longer used
Management
Pharmacological
No neurological involvement:
- Hydroxocobalamin 1mg IM on alternate days × 2 weeks (loading)
- Then hydroxocobalamin 1mg IM every 2–3 months for life (pernicious anaemia)
WITH neurological involvement (URGENT):
- Hydroxocobalamin 1mg IM on alternate days until no further improvement (may be several weeks/months)
- Then hydroxocobalamin 1mg IM every 2 months for life
Dietary deficiency:
- Oral cyanocobalamin 50–150mcg daily may suffice (if adherent)
- Dietary advice: fortified foods, consider lifelong supplementation for vegans
CRITICAL:
- If B12 and folate both deficient: treat B12 FIRST — giving folate alone may precipitate/worsen SACD
- Hypokalaemia may occur during early treatment (increased erythropoiesis uses potassium) — monitor
Referral Criteria
- Haematology: diagnostic uncertainty, pancytopenia, suspected MDS
- Neurology: SACD or other neurological complications
- Gastroenterology: pernicious anaemia surveillance (debated), malabsorption investigation
Prognosis
- Haematological: excellent response; reticulocyte rise within 5–7 days; Hb normalises in 6–8 weeks
- Neurological: if treated early, many symptoms improve; if delayed (>6 months), may be irreversible
- Pernicious anaemia: lifelong B12 replacement; ~2–3× increased risk of gastric cancer (debated surveillance)
- SACD: early treatment is critical — prognosis directly related to duration before treatment
- Dietary: excellent if supplementation maintained
Other Relevant Information
B12 vs Folate Deficiency Comparison
| Feature | B12 Deficiency | Folate Deficiency |
|---|---|---|
| Anaemia | Megaloblastic | Megaloblastic |
| Neurological | YES (SACD, peripheral neuropathy) | NO |
| MMA | Elevated | Normal |
| Homocysteine | Elevated | Elevated |
| Treatment | Hydroxocobalamin IM | Folic acid PO |